SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In
 
We’re going down soon, to move to a new Data Center today.  We’ll be up ASAP.  Sorry.

Allogene Therapeutics, Inc. – ‘D’ on 4/19/18

On:  Thursday, 4/19/18, at 12:02pm ET   ·   Effective:  4/19/18   ·   Accession #:  1737287-18-1   ·   File #:  21-310557

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of                Filer                Filing    For·On·As Docs:Size

 4/19/18  Allogene Therapeutics, Inc.       D           4/19/18    1:11K

Notice of an Offering of Securities Made Without Registration   —   Form D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: D           Notice of an Offering of Securities Made Without    HTML     11K 
                          Registration -- primary_doc.xml/7.8


        

This ‘D’ Document is an XML Data File that may be rendered in various formats:

  Form D    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
XML Data rendering:  Notice of an Exempt Offering of Securities
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<edgarSubmission>
<schemaVersion> X0708 </schemaVersion>
<submissionType> D </submissionType>
<testOrLive> LIVE </testOrLive>
<primaryIssuer>
<cik> 0001737287 </cik>
<entityName> Allogene Therapeutics, Inc. </entityName>
<issuerAddress>
<street1> 270 LITTLEFIELD AVE </street1>
<city> SOUTH SAN FRANCISCO </city>
<stateOrCountry> CA </stateOrCountry>
<stateOrCountryDescription> CALIFORNIA </stateOrCountryDescription>
<zipCode> 94080 </zipCode>
</issuerAddress>
<issuerPhoneNumber> (212) 871-7920 </issuerPhoneNumber>
<jurisdictionOfInc> DELAWARE </jurisdictionOfInc>
<issuerPreviousNameList>
<value> None </value>
</issuerPreviousNameList>
<edgarPreviousNameList>
<value> None </value>
</edgarPreviousNameList>
<entityType> Corporation </entityType>
<yearOfInc>
<withinFiveYears> true </withinFiveYears>
<value> 2017 </value>
</yearOfInc>
</primaryIssuer>
<relatedPersonsList>
<relatedPersonInfo>
<relatedPersonName>
<firstName> JOSHUA </firstName>
<middleName> A. </middleName>
<lastName> KAZAM </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> C/O ALLOGENE THERAPEUTICS, INC. </street1>
<street2> 270 LITTLEFIELD AVE </street2>
<city> SOUTH SAN FRANCISCO </city>
<stateOrCountry> CA </stateOrCountry>
<stateOrCountryDescription> CALIFORNIA </stateOrCountryDescription>
<zipCode> 94080 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Executive Officer </relationship>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> DAVID </firstName>
<middleName> M. </middleName>
<lastName> TANEN </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> C/O ALLOGENE THERAPEUTICS, INC. </street1>
<street2> 270 LITTLEFIELD AVE </street2>
<city> SOUTH SAN FRANCISCO </city>
<stateOrCountry> CA </stateOrCountry>
<stateOrCountryDescription> CALIFORNIA </stateOrCountryDescription>
<zipCode> 94080 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Executive Officer </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> ARIE </firstName>
<lastName> BELLDEGRUN </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> C/O ALLOGENE THERAPEUTICS, INC. </street1>
<street2> 270 LITTLEFIELD AVE </street2>
<city> SOUTH SAN FRANCISCO </city>
<stateOrCountry> CA </stateOrCountry>
<stateOrCountryDescription> CALIFORNIA </stateOrCountryDescription>
<zipCode> 94080 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> DAVID </firstName>
<lastName> BONDERMAN </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> C/O ALLOGENE THERAPEUTICS, INC. </street1>
<street2> 270 LITTLEFIELD AVE </street2>
<city> SOUTH SAN FRANCISCO </city>
<stateOrCountry> CA </stateOrCountry>
<stateOrCountryDescription> CALIFORNIA </stateOrCountryDescription>
<zipCode> 94080 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> DAVID </firstName>
<lastName> CHANG </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> C/O ALLOGENE THERAPEUTICS, INC. </street1>
<street2> 270 LITTLEFIELD AVE </street2>
<city> SOUTH SAN FRANCISCO </city>
<stateOrCountry> CA </stateOrCountry>
<stateOrCountryDescription> CALIFORNIA </stateOrCountryDescription>
<zipCode> 94080 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> ROBERT </firstName>
<lastName> ABRAHAM </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> C/O ALLOGENE THERAPEUTICS, INC. </street1>
<street2> 270 LITTLEFIELD AVE </street2>
<city> SOUTH SAN FRANCISCO </city>
<stateOrCountry> CA </stateOrCountry>
<stateOrCountryDescription> CALIFORNIA </stateOrCountryDescription>
<zipCode> 94080 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> JOHN </firstName>
<lastName> DEYOUNG </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> C/O ALLOGENE THERAPEUTICS, INC. </street1>
<street2> 270 LITTLEFIELD AVE </street2>
<city> SOUTH SAN FRANCISCO </city>
<stateOrCountry> CA </stateOrCountry>
<stateOrCountryDescription> CALIFORNIA </stateOrCountryDescription>
<zipCode> 94080 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> FRANZ </firstName>
<lastName> HUMER </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> C/O ALLOGENE THERAPEUTICS, INC. </street1>
<street2> 270 LITTLEFIELD AVE </street2>
<city> SOUTH SAN FRANCISCO </city>
<stateOrCountry> CA </stateOrCountry>
<stateOrCountryDescription> CALIFORNIA </stateOrCountryDescription>
<zipCode> 94080 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> TODD </firstName>
<lastName> SISITSKY </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> C/O ALLOGENE THERAPEUTICS, INC. </street1>
<street2> 270 LITTLEFIELD AVE </street2>
<city> SOUTH SAN FRANCISCO </city>
<stateOrCountry> CA </stateOrCountry>
<stateOrCountryDescription> CALIFORNIA </stateOrCountryDescription>
<zipCode> 94080 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> OWEN </firstName>
<lastName> WITTE </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> C/O ALLOGENE THERAPEUTICS, INC. </street1>
<street2> 270 LITTLEFIELD AVE </street2>
<city> SOUTH SAN FRANCISCO </city>
<stateOrCountry> CA </stateOrCountry>
<stateOrCountryDescription> CALIFORNIA </stateOrCountryDescription>
<zipCode> 94080 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
</relatedPersonsList>
<offeringData>
<industryGroup>
<industryGroupType> Biotechnology </industryGroupType>
</industryGroup>
<issuerSize>
<revenueRange> Decline to Disclose </revenueRange>
</issuerSize>
<federalExemptionsExclusions>
<item> 06b </item>
</federalExemptionsExclusions>
<typeOfFiling>
<newOrAmendment>
<isAmendment> false </isAmendment>
</newOrAmendment>
<dateOfFirstSale>
<value> 2018-04-06 </value>
</dateOfFirstSale>
</typeOfFiling>
<durationOfOffering>
<moreThanOneYear> false </moreThanOneYear>
</durationOfOffering>
<typesOfSecuritiesOffered>
<isEquityType> true </isEquityType>
</typesOfSecuritiesOffered>
<businessCombinationTransaction>
<isBusinessCombinationTransaction> false </isBusinessCombinationTransaction>
<clarificationOfResponse></clarificationOfResponse>
</businessCombinationTransaction>
<minimumInvestmentAccepted> 0 </minimumInvestmentAccepted>
<salesCompensationList></salesCompensationList>
<offeringSalesAmounts>
<totalOfferingAmount> 411770409 </totalOfferingAmount>
<totalAmountSold> 411770409 </totalAmountSold>
<totalRemaining> 0 </totalRemaining>
<clarificationOfResponse> The consideration for $111,770,405 of the total offering amount was non-cash consideration, and the consideration for $150,000,002 of the total offering amount was capital commitments. </clarificationOfResponse>
</offeringSalesAmounts>
<investors>
<hasNonAccreditedInvestors> false </hasNonAccreditedInvestors>
<totalNumberAlreadyInvested> 23 </totalNumberAlreadyInvested>
</investors>
<salesCommissionsFindersFees>
<salesCommissions>
<dollarAmount> 0 </dollarAmount>
</salesCommissions>
<findersFees>
<dollarAmount> 0 </dollarAmount>
</findersFees>
<clarificationOfResponse></clarificationOfResponse>
</salesCommissionsFindersFees>
<useOfProceeds>
<grossProceedsUsed>
<dollarAmount> 0 </dollarAmount>
</grossProceedsUsed>
<clarificationOfResponse></clarificationOfResponse>
</useOfProceeds>
<signatureBlock>
<authorizedRepresentative> false </authorizedRepresentative>
<signature>
<issuerName> Allogene Therapeutics, Inc. </issuerName>
<signatureName> /s/ David M. Tanen </signatureName>
<nameOfSigner> David M. Tanen </nameOfSigner>
<signatureTitle> Secretary </signatureTitle>
<signatureDate> 2018-04-19 </signatureDate>
</signature>
</signatureBlock>
</offeringData>
</edgarSubmission>


↑Top
Filing Submission 0001737287-18-000001   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., May 11, 8:13:40.1am ET